Cold sterilisation of medical devices and pharmaceutical products
Ionisos is the leader of the French market of cold sterilisation services with a c. 70% market share. The group operates 6 units, including 3 sites featuring gamma irradiation, 2 sites featuring beta irradiation et 1 ethylene oxide site. AtriA Capital Partenaires arranged an MBO on Ionisos in 2007 with the management team.
Back to the investments